DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Dexcom Inc.

DXCMNASDAQ$77.94−$0.38 (−0.49%)Market closed

Price Chart

Daily

Key facts

Market Cap
$29.79B
P/E
36.4x
P/B
11.08x
ROE
34.5%

Dexcom Inc.

Healthcare · Medical Devices · FY 2025

Dexcom Inc. is a prominent player in the medical technology sector, specializing in continuous glucose monitoring (CGM) systems for diabetes management. The company's primary function is to develop and distribute innovative CGM devices that provide real-time glucose readings, allowing individuals with diabetes to make informed decisions about their health. Dexcom’s products play a critical role in healthcare by offering an alternative to traditional fingerstick testing, thus improving quality of life for many users. The company impacts several sectors, most notably within healthcare and technology, by integrating advanced data analytics and wireless technology into its monitoring systems. This not only aids individuals in managing their glucose levels but also supports healthcare providers in delivering better patient care through data-driven insights. In the financial market, Dexcom Inc. is recognized for its contributions to the growing field of digital health solutions. The company has established itself as a leader in its niche, continuously pushing the boundaries of technology to offer more precise and user-friendly glucose monitoring options. Founded in 1999 and headquartered in San Diego, California, Dexcom remains at the forefront of diabetes management solutions.

CEO
Mr. Jacob Steven Leach
Employees
10,200

Company Statistics

Valuation

P/E
36.4x
P/B
11.08x
P/S
6.52x
EV/EBITDA
22.7x
P/FCF
28.2x

Margins

Gross
60.1%
EBITDA
29.1%
Operating
19.6%
Pre-Tax
23.3%
Net
17.9%

Returns

ROA
13.0%
ROE
34.5%
ROIC
17.3%

Growth (CAGR)

Rev 3Yr
17.0%
Rev 5Yr
19.3%
Op Inc 3Yr
32.6%
Net Inc 3Yr
34.8%

Financial Health

Cash & Cash Equivalents
$917.7M
Net Debt
$2.68B
Debt/Equity
130.9%
Interest Cov
—

Profile

Revenue
$4.66B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Dexcom Inc. (DXCM) Stock Forecast 2026 $77.94 — Price, Financials & Analyst Targets | AlphaLenz